SCHEMBL31014100

SCHEMBL31014100

CC1(C)OC(=O)c2c(O)cc(Cl)cc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
HSP90AA1 P07900 1/20 0.34
LMNA P02545 2/20 0.33
PTPN1 P18031 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
CYP19A1 P11511 1/20 0.33
MYLK Q15746 1/20 0.32
DAO P14920 1/20 0.32
HSD17B10 Q99714 2/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TTR P02766 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26604721 1.00 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL9155082 0.84 ALDH1A1 (0.57) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL15762161 0.83 MEN1 (0.42) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL30645929 0.83 MEN1 (0.42) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL31013939 0.81 ALDH1A1 (0.40) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL15348611 0.79 TDP1 (0.58) ALDH1A1TDP1L3MBTL1GAAMAPT
SCHEMBL31335652 0.79 TDP1 (0.36) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL31013887 0.78 ALDH1A1 (0.37) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL31013901 0.78 ALDH1A1 (0.37) ALDH1A1TDP1L3MBTL1TSHRCYP1A2
SCHEMBL31562510 0.75 TDP1 (0.48) ALDH1A1TDP1L3MBTL1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116891-A1 Oxazepin Derivative TEIJIN PHARMA LTD (JP) 2026-04-30 US disclosed
EP-4651955-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2025-11-26 EP disclosed
EP-4512811-A1 OXAZEPINE DERIVATIVE Teijin Pharma Limited (JP) 2025-02-26 EP disclosed
WO-2024153947-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2024-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116891-A1 Oxazepin Derivative HCRTR2, HCRTR1, OXTR ALDH1A1 754/4885TDP1 4806/4885L3MBTL1 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.